129 related articles for article (PubMed ID: 26806830)
1. Epigenetic memory in kidney diseases.
Mimura I
Kidney Int; 2016 Feb; 89(2):274-7. PubMed ID: 26806830
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic regulation of the thioredoxin-interacting protein (TXNIP) gene by hyperglycemia in kidney.
De Marinis Y; Cai M; Bompada P; Atac D; Kotova O; Johansson ME; Garcia-Vaz E; Gomez MF; Laakso M; Groop L
Kidney Int; 2016 Feb; 89(2):342-53. PubMed ID: 26806835
[TBL] [Abstract][Full Text] [Related]
3. The role of epigenetics in the pathology of diabetic complications.
Villeneuve LM; Natarajan R
Am J Physiol Renal Physiol; 2010 Jul; 299(1):F14-25. PubMed ID: 20462972
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic regulation of glucose-stimulated osteopontin (OPN) expression in diabetic kidney.
Cai M; Bompada P; Atac D; Laakso M; Groop L; De Marinis Y
Biochem Biophys Res Commun; 2016 Jan; 469(1):108-113. PubMed ID: 26592666
[TBL] [Abstract][Full Text] [Related]
5. Thioredoxin-interacting protein regulates lipid metabolism via Akt/mTOR pathway in diabetic kidney disease.
Du C; Wu M; Liu H; Ren Y; Du Y; Wu H; Wei J; Liu C; Yao F; Wang H; Zhu Y; Duan H; Shi Y
Int J Biochem Cell Biol; 2016 Oct; 79():1-13. PubMed ID: 27497988
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic mechanisms.
Villeneuve LM; Natarajan R
Contrib Nephrol; 2011; 170():57-65. PubMed ID: 21659758
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic Risk Profile of Diabetic Kidney Disease in High-Risk Populations.
Xu L; Natarajan R; Chen Z
Curr Diab Rep; 2019 Feb; 19(3):9. PubMed ID: 30730019
[TBL] [Abstract][Full Text] [Related]
8. Thioredoxin-interacting protein: a potential therapeutic target for treatment of progressive fibrosis in diabetic nephropathy.
Tan CY; Weier Q; Zhang Y; Cox AJ; Kelly DJ; Langham RG
Nephron; 2015; 129(2):109-27. PubMed ID: 25662516
[TBL] [Abstract][Full Text] [Related]
9. Epigenetics: deciphering its role in diabetes and its chronic complications.
Villeneuve LM; Reddy MA; Natarajan R
Clin Exp Pharmacol Physiol; 2011 Jul; 38(7):451-9. PubMed ID: 21309809
[TBL] [Abstract][Full Text] [Related]
10. Thioredoxin-Interacting Protein Deficiency Protects against Diabetic Nephropathy.
Shah A; Xia L; Masson EA; Gui C; Momen A; Shikatani EA; Husain M; Quaggin S; John R; Fantus IG
J Am Soc Nephrol; 2015 Dec; 26(12):2963-77. PubMed ID: 25855771
[TBL] [Abstract][Full Text] [Related]
11. Thioredoxin interacting protein (TXNIP) regulates tubular autophagy and mitophagy in diabetic nephropathy through the mTOR signaling pathway.
Huang C; Zhang Y; Kelly DJ; Tan CY; Gill A; Cheng D; Braet F; Park JS; Sue CM; Pollock CA; Chen XM
Sci Rep; 2016 Jul; 6():29196. PubMed ID: 27381856
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic mechanisms in diabetic complications and metabolic memory.
Reddy MA; Zhang E; Natarajan R
Diabetologia; 2015 Mar; 58(3):443-55. PubMed ID: 25481708
[TBL] [Abstract][Full Text] [Related]
13. Thioredoxin interacting protein expression in the urinary sediment associates with renal function decline in type 1 diabetes.
Monteiro MB; Santos-Bezerra DP; Thieme K; Admoni SN; Perez RV; Machado CG; Queiroz MS; Nery M; Oliveira-Souza M; Woronik V; Passarelli M; Giannella-Neto D; Machado UF; Corrêa-Giannella ML
Free Radic Res; 2016; 50(1):101-10. PubMed ID: 26480949
[TBL] [Abstract][Full Text] [Related]
14. The Histone Methyltransferase Enzyme Enhancer of Zeste Homolog 2 Protects against Podocyte Oxidative Stress and Renal Injury in Diabetes.
Siddiqi FS; Majumder S; Thai K; Abdalla M; Hu P; Advani SL; White KE; Bowskill BB; Guarna G; Dos Santos CC; Connelly KA; Advani A
J Am Soc Nephrol; 2016 Jul; 27(7):2021-34. PubMed ID: 26534922
[TBL] [Abstract][Full Text] [Related]
15. Epigenetics in diabetic nephropathy, immunity and metabolism.
Keating ST; van Diepen JA; Riksen NP; El-Osta A
Diabetologia; 2018 Jan; 61(1):6-20. PubMed ID: 29128937
[TBL] [Abstract][Full Text] [Related]
16. PDT-induced epigenetic changes in the mouse cerebral cortex: a protein microarray study.
Demyanenko SV; Uzdensky AB; Sharifulina SA; Lapteva TO; Polyakova LP
Biochim Biophys Acta; 2014 Jan; 1840(1):262-70. PubMed ID: 24055374
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic mechanisms and memory strength: a comparative study.
Federman N; Zalcman G; de la Fuente V; Fustiñana MS; Romano A
J Physiol Paris; 2014; 108(4-6):278-85. PubMed ID: 24978317
[TBL] [Abstract][Full Text] [Related]
18. Thioredoxin interacting protein (TXNIP) induces inflammation through chromatin modification in retinal capillary endothelial cells under diabetic conditions.
Perrone L; Devi TS; Hosoya K; Terasaki T; Singh LP
J Cell Physiol; 2009 Oct; 221(1):262-72. PubMed ID: 19562690
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic bivalent marking is permissive to the synergy of HDAC and PARP inhibitors on TXNIP expression in breast cancer cells.
Baldan F; Mio C; Lavarone E; Di Loreto C; Puglisi F; Damante G; Puppin C
Oncol Rep; 2015 May; 33(5):2199-206. PubMed ID: 25812606
[TBL] [Abstract][Full Text] [Related]
20. Recent developments in epigenetics of acute and chronic kidney diseases.
Reddy MA; Natarajan R
Kidney Int; 2015 Aug; 88(2):250-61. PubMed ID: 25993323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
